Shunqing Wang

机构：Guangzhou First People's Hospital, Guangzhou Medical University · ORCID：0000-0001-9418-4901

发表论文 201 篇 · 总被引 2877 次 · h-index 29

代表论文

• A first-in-class JAK/ROCK inhibitor, rovadicitinib, for glucocorticoid-refractory or -dependent chronic GVHD (2025 · Blood · 被引 18)
• Comparable survival outcomes in HLA-Matched and haploidentical hematopoietic stem cell transplantation for severe aplastic anemia patients aged 40–50: A CBMTR Registry-based propensity score matching analysis over the last decade (2025 · Cancer Letters · 被引 15)
• Research on herd sheep facial recognition based on multi-dimensional feature information fusion technology in complex environment (2025 · Frontiers in Veterinary Science · 被引 10)
• Innovative evaluation of selinexor and JQ1 synergy in leukemia therapy via C-MYC inhibition (2025 · Journal of Translational Medicine · 被引 6)
• Excessive Use of Polygonatum sibiricum Causes No Acute Lethality but Induces Multiple Toxic Effects in Mice (2025 · Journal of Applied Toxicology · 被引 4)
• The endothelial activation and stress index as a risk factor for all-cause mortality in patients with anemia: a nationwide retrospective cross-sectional study (2025 · Hematology · 被引 2)